MOCCA
Trial Description:
A Multicentre Phase II Randomised Trial of Durvalumab (MEDI4736) Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Completed
Contact person:
dtan